MetLife Investment Advisors »

Intra Cellular Therapies shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5M 49k 71.62
2023-09-30 $2.6M 49k 52.09
2023-06-30 $3.1M 49k 63.32
2023-03-31 $2.6M 48k 54.15
2022-12-31 $2.6M 49k 52.92
2022-09-30 $2.3M 49k 46.53
2022-06-30 $2.7M 48k 57.08
2022-03-31 $2.6M 43k 61.19
2021-12-31 $1.3M 24k 52.34
2021-09-30 $987k 27k 37.28
2021-06-30 $1.1M 27k 40.82
2021-03-31 $898k 27k 33.93
2020-12-31 $842k 27k 31.81
2020-09-30 $679k 27k 25.66
2020-06-30 $679k 27k 25.66
2020-03-31 $358k 23k 15.37
2019-12-31 $673k 20k 34.31
2019-09-30 $147k 20k 7.47
2019-06-30 $254k 20k 12.96
2019-03-31 $239k 20k 12.18
2018-12-31 $223k 20k 11.39
2018-09-30 $663k 31k 21.71
2018-06-30 $346k 20k 17.65
2018-03-31 $413k 20k 21.06
2017-12-31 $246k 17k 14.48